With Two Deals In Place, Amerigen Looks To Leverage China For Branded Generics
This article was originally published in PharmAsia News
U.S. startup looks to tap into China’s generic market – both in China and back home in the states.
You may also be interested in...
Shanghai Fosun Omni Pharma Execs On China Following A Different Pharma Model Than India: An Interview With PharmAsia News (Part 1 of 2)
Continuing with a double-digit growth rate, China remained a leading driver for Sanofi’s global business in the fourth quarter. Going digital and building local partnerships emerged as key themes for Sanofi China to explore more opportunities, although it may face testing problems for its vaccine business in the country.